Encompass Health Corporation (EHC): Price and Financial Metrics


Encompass Health Corporation (EHC)

Today's Latest Price: $79.48 USD

2.16 (-2.65%)

Updated Feb 24 3:35pm

Add EHC to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 7 in Medical - Hospitals

See all "A" rated Strong Buy stocks

EHC Stock Summary

  • Encompass Health Corp's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 84.62% of US listed stocks.
  • With a one year PEG ratio of 278.63, Encompass Health Corp is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 85.45% of US stocks.
  • Encompass Health Corp's stock had its IPO on September 13, 1989, making it an older stock than 87.91% of US equities in our set.
  • If you're looking for stocks that are quantitatively similar to Encompass Health Corp, a group of peers worth examining would be SNV, AFG, UGI, RL, and RBA.
  • EHC's SEC filings can be seen here. And to visit Encompass Health Corp's official web site, go to www.encompasshealth.com.
EHC Daily Price Range
EHC 52-Week Price Range

EHC Stock Price Chart More Charts


EHC Price/Volume Stats

Current price $79.48 52-week high $83.30
Prev. close $81.64 52-week low $56.74
Day low $78.87 Volume 342,542
Day high $80.41 Avg. volume 632,002
50-day MA $75.45 Dividend yield 1.37%
200-day MA $66.91 Market Cap 7.84B

Encompass Health Corporation (EHC) Company Bio


Encompass Health Corporation, formerly Healthsouth, owns and operates inpatient rehabilitation hospitals in the United States. The company provides specialized rehabilitative treatment on an inpatient and outpatient basis. The company was founded in 1983 and is based in Birmingham, Alabama.

EHC Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$79.48$25.25 -69%

We started the process of determining a valid price forecast for Encompass Health Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Encompass Health Corp ranked in the 25st percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Encompass Health Corp, consider:

  • The stock's equity weight, or the proportion of capital from equity relative to debt, is 69. Its equity weight surpasses that of only 18.63% of free cash flow generating stocks in the Healthcare sector.
  • The business' balance sheet suggests that 31% of the company's capital is sourced from debt; this is greater than 61.67% of the free cash flow producing stocks we're observing.
  • Encompass Health Corp's weighted average cost of capital (WACC) is 8%; for context, that number is higher than only 11.84% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-70%
1%-69%
2%-69%
3%-69%
4%-68%
5%-68%

ICLR, NEO, AHPI, GKOS, and XRAY can be thought of as valuation peers to EHC, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.


EHC Latest News Stream


Event/Time News Detail
Loading, please wait...

EHC Latest Social Stream


Loading social stream, please wait...

View Full EHC Social Stream

EHC Price Returns

1-mo 0.81%
3-mo 12.18%
6-mo 35.87%
1-year 22.80%
3-year 98.81%
5-year 103.67%
YTD 14.74%
2019 14.26%
2018 26.89%
2017 22.36%
2016 21.34%
2015 -7.48%

EHC Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full EHC Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7663 seconds.